Leaving UL Solutions website
Within UL Solutions we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Approved/Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brand, we have processes in place to identify and manage any potential conflicts of interest and maintain impartiality. UL Solutions is unable to provide consultancy services to EU MDD, MDR or IVDD Notified Body, UKCA MD Approved Body or MDSAP Customers.
  • Press Release

UL Solutions Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

UL Solutions Inc. (the “Issuer”) today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to a proposed secondary offering by UL Standards & Engagement, the nonprofit organization that is currently the sole stockholder of the Issuer, of Class A common stock of the Issuer.

UL Solutions logo

October 2, 2023

NORTHBROOK, ILLINOIS – October 2, 2023 — UL Solutions Inc. (the “Issuer”) today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to a proposed secondary offering by UL Standards & Engagement, the nonprofit organization that is currently the sole stockholder of the Issuer, of Class A common stock of the Issuer. The Issuer does not expect to receive any proceeds from the proposed offering.  

The proposed offering would constitute the Issuer’s initial public offering. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed initial public offering is subject to market and other conditions, including completion of the SEC’s review of the registration statement. 

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). This announcement is being issued in accordance with Rule 135 under the Securities Act. 

 

Contacts: 

Media: 

Kathy Fieweger 

Senior Vice President - Communications 

Kathy.fieweger@ul.com 

312-852-5156